Arrivent BioPharma, Inc. (AVBP)
22.82
-0.27
(-1.17%)
USD |
NASDAQ |
Feb 20, 13:43
Arrivent BioPharma Total Assets (Quarterly) : 326.56M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.714B |
| AIM ImmunoTech, Inc. | 5.494M |
| Bristol Myers Squibb Co. | 90.04B |
| Annexon, Inc. | 229.14M |
| Spruce Biosciences, Inc. | 15.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.56M |
| Shareholders Equity (Quarterly) | 305.00M |
| Debt to Equity Ratio | 0.0002 |
| Current Ratio | 14.90 |
| Net Debt Paydown Yield | 0.01% |